ACUR — Acura Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Acura Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	2.22	0.091	0.862	0.413	0.065
Net Total Accounts Receivable
Net Total Receivables	0.071	0.204	0.194	0.627	0.158
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2.57	0.461	1.18	1.18	0.372
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.679	0.606	0.54	0.484	0.488
Net Intangible Assets
Long Term Notes Receivable
Total Assets	4.6	2.15	2.56	1.74	0.86
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.63	1.44	1.07	7.52	0.515
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.63	5.77	7.3	7.63	0.682
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.027	-3.62	-4.74	-5.89	0.178
Total Liabilities & Shareholders' Equity	4.6	2.15	2.56	1.74	0.86
Total Common Shares Outstanding